XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Xenon Pharmaceuticals Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$35.08+1.59 (+4.75%)
Close on Oct 19, 2026
- Market cap
- $3.49B
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Xenon Pharmaceuticals has not reported a dividend
No dividend per share appears in Xenon Pharmaceuticals's annual filings since fiscal 2011.